Studies have shown that KAT7 enhances the mechanical transduction pathway and membrane elasticity of ovarian cancer cells through the overexpression of preferential acetylation histone H4 of co-mediator JADE2, thus improving the migration ability and invasiveness of ovarian cancer cells (Quintela et al., 2019; Gao et al., 2021). This evidence concerns the gene KAT7 and ovarian carcinoma.